Buy now

  

|

Buy now

Proven results in Type 2 diabetes - Now you know

Proven results in Type 2 diabetes - Now you know

FreeStyle Libre is clinically proven to reduce HbA1c in people living with type 2 diabetes (T2D)15,17,21,22

Non-insulin therapy

A1c inside a circle next to a wide blue downwards arrow showing a decrease of 1.6 percent.

After 22 weeks

In people with T2D who were using non-insulin therapy and FreeStyle Libre (p<0.001 vs. baseline A1c)21

A downward pointing yellow arrow.

Baseline A1c:

10.1%

Follow-up A1c:

8.5%

FreeStyle Libre has been proven to increase Time in Range by 43%3

graphic of clock and blue arrow pointing upwards - increases time in range by 43 percent

More frequent scanning of the FreeStyle Libre sensor has been proven to increase Time in Range

Lowering HbA1c reduces your risk of diabetes related complications

Use of the FreeStyle Libre system is associated with significant reduction in diabetes-related hospital admissions8,11

Reduction in hospital admissions by 66 percent

Reduction in hospital admissions

Use of FreeStyle Libre reduced diabetes related hospital admissions11

Reduction in work absenteeism by 58 percent

Reduction in work absenteeism

Use of FreeStyle Libre led to reduction in work absenteeism over 1 year11

Disclaimer - Images are for illustration purpose only. No actual patient data. Any person depicted in the photos is a model

Hospital admission decreased from 13.7% to 4.7% at 12 months (p=0.005). This study was done with the FreeStyle Libre system on 1365 people with type 1 and type 2 diabetes on insulin. The duration of the study was 1 year and the findings were measured A1c levels, hypoglycaemic and patient-reported outcomes.13

Abbreviations: HbA1c: glycated haemoglobin; MDI: multiple daily injections; SMBG: self-monitoring of blood glucose; T2D: type 2 diabetes.

References: 8. Charleer S, et al. Quality of Life and Glucose Control After 1 Year of Nationwide Reimbursement of Intermittently Scanned Continuous Glucose Monitoring in Adults Living With Type 1 Diabetes (FUTURE): A Prospective Observational Real-World Cohort Study. Diabetes Care 2020;43(2):389-397. https://doi.org/10.2337/dc19-1610. 11. Fokkert M, et al. Improved well-being and decreased disease burden after 1-year use of flash glucose monitoring (FLARE-NL4). BMJ Open Diabetes Research and Care 2019;7:e000809. doi: 10.1136/bmjdrc-2019-000809. 15. Hirst JA, et al. Quantifying the effect of metformin treatment and dose on glycemic control. Diabetes Care. 2012 Feb;35(2):446-54. doi: 10.2337/dc11-1465. 17. Miller E, Brandner L, Wright E. HbA1c reduction after initiation of the FreeStyle Libre system in type 2 diabetes patients on long-acting insulin or non-insulin therapy [84-LB]. Poster presented at: American Diabetes (ADA) 80th Scientific Sessions. 21. Wright E, et al. Diabetes Spectrum. Use of Flash Continuous Glucose Monitoring Is Associated With A1C Reduction in People With Type 2 Diabetes Treated With Basal Insulin or Noninsulin Therapy. 2021;34(2):184–189. https://doi.org/10.2337/ds20-0069.

Cookie Policy and Disclaimer

FreeStyle Libre uses cookies to give you the best website experience. By using our website, you consent to the use of cookies per our privacy policy. FreeStyle.abbott/in-en is a product specific website only intended for residents of India.

Change country
India (en-IN)

The FreeStyle Libre continuous glucose monitoring system is indicated for measuring interstitial fluid glucose levels in people (age 4 and older) with diabetes mellitus. The indication for children (age 4 – 17) is limited to those who are supervised by a caregiver at least 18 years old who is responsible for supervising, managing, and assisting the child in using the FreeStyle Libre system and interpreting its readings.

Health care professionals and consumers should be aware about the limitations of available scientific evidence for use of this device in any other groups of patients who require diabetes management. Always read the label and use as directed.

For more information call Customer Service on 1800 2100 998

© 2022 Abbott. All Rights Reserved. FreeStyle, Libre, and related brand marks are marks of Abbott. Other trademarks are the property of their respective owners. Please read legal notice for further details

No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott Healthcare Private Limited, except to identify the product or services of the company. This website and the information contained herein is intended for use by residents of India. The product images are for illustrative purposes only.

Disclaimer
www.FreeStyleLibre.co.in is a product-specific website intended only for residents of India. If you are resident of another country, please contact your local Abbott affiliate to obtain the appropriate product information for your country of residence.

Abbott Logo

© 2022 Abbott. FreeStyle, Libre, and related brand marks are marks of Abbott. Other trademarks are the property of their respective owners. Please read legal notice for further details. ADC-68213 v1.0 12/22

You are about to exit the Abbott family of websites for a 3rd party website

Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott.

The website that you have requested also may not be optimized for your screen size.

Do you wish to continue and exit this website?